Your Health, We Care
Stiripentol is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more. There are no clinical data to support the use of Stiripentol as monotherapy in Dravet syndrome.
from FDA，2022.07
Stiripentol significantly reduces generalized seizures by enhancing GABAergic ne···【more】
Release date：2024-08-29Recommended：173
Stiripentol is a drug that reduces seizures by modulating GABA receptors, especi···【more】
Release date：2024-08-28Recommended：178
Stiripentol was approved by the FDA in 2018 for significantly improving seizure ···【more】
Release date：2024-08-28Recommended：191
